1 |
Panigrahi MK, Pradhan G, Sahoo N, et al.Primary pulmonary synovial sarcoma: A reappraisal.J Cancer Res Ther, 2018, 14(3): 481-489.
|
2 |
Li C, Krasniqi F, Donners R, et al.Synovial sarcoma: the misdiagnosed sarcoma [J].EFORT Open Rev, 2024, 9(3): 190-201.
|
3 |
Jacobs AJ, Morris CD, Levin AS.Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas [J].Clin Orthop Relat Res, 2018, Mar, 476(3): 589-598.
|
4 |
武兵, 朱慧, 胡培安, 等.滑膜肉瘤的MRI 表现分析 [J].肿瘤影像学,2021, 30(4): 269-274.
|
5 |
裴家鑫, 吕新全, 周雅淑, 等.横纹肌肉瘤组织Ki-67 表达与临床病理特征及预后的关系[J].中华实用诊断与治疗杂志, 2024, 38(7):674-678.
|
6 |
李文杰, 苗成利, 肖萌萌, 等.腹盆部孤立性纤维性肿瘤的临床分析[J].中华普通外科杂志, 2020, 35(6): 443-443.
|
7 |
王西昌, 孙潇, 崔学武, 等.未分化多形性肉瘤的影像特点 [J].宁夏医科大学学报, 2022, 44(1): 44-47, 54.
|
8 |
Choi JH, Ro JY.Retroperitoneal sarcomas: an update on the diagnostic pathology approach [J].Diagnostics (Basel), 2020, 10(9): 642.
|
9 |
陈少华, 黄种心, 林娜, 等.滑膜肉瘤的诊断及预后治疗新进展 [J].临床与实验病理学杂志, 2020, 36(8): 947-950.
|
10 |
Raquib AR, Hofvander J, Ta M, et al.Expanding the use of an SS18-SSX antibody for molecular assays in synovial sarcoma [J].Appl Immunohistochem Mol Morphol, 2022, 30(8): 531-539.
|
11 |
Lasota J, Chłopek M, Kaczorowski M, et al.Utility of immunohistochemistry with antibodies to SS18-SSX chimeric proteins and C-terminus of SSX protein for synovial sarcoma differential diagnosis[J].Am J Surg Pathol, 2024, 48(1): 97-105.
|
12 |
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, et al.Survival prognostic factors in unresectable/advanced primary thoracic sarcomas [J].J Thorac Dis, 2022, 14(9): 3376-3385.
|
13 |
王军, 刘鲲鹏, 姚兰, 等.腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J/OL].中华临床医师杂志(电子版), 2023, 17(8):844-849.
|
14 |
Stacchiotti S, Van Tine BA.Synovial sarcoma: current concepts and future perspectives [J].J Clin Oncol, 2018, 36(2): 180-187.
|
15 |
Mastoraki A, Schizas D, Karavolia DM, et al.Primary synovial sarcoma of the kidney: diagnostic approach and therapeutic modalities for a rare nosological entity [J].J Pers Med, 2022, 12(9): 1450.
|
16 |
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, et al.Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas [J].J Cancer Res Clin Oncol, 2023, 149(9): 5479-5491.
|
17 |
Chi Y, Fang Z, Hong X, et al.Safety and efficacy of anlotinib, a multikinase angiogenesis inhibitor, in patients with refractory metastatic soft-tissue sarcoma [J].Clin Cancer Res, 2018, 24(21): 5233-5238.
|
18 |
Tian Z, Dong S, Yang Y, et al.Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study [J].BMC Cancer, 2022, 22(1): 56.
|
19 |
Argani P, Zhang L, Sung YS, et al.Novel SS18-NEDD4 gene fusion in a primary renal synovial sarcoma [J].Genes Chromosomes Cancer, 2020,59(3): 203-208.
|
20 |
Yoshida A, Arai Y, Satomi K, et al.Identification of novel SSX1 fusions in synovial sarcoma [J].Mod Pathol, 2022, 35(2): 228-239.
|